vs
Side-by-side financial comparison of Scilex Holding Co (SCLX) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $4.2M, roughly 1.1× Virgin Galactic Holdings, Inc). Scilex Holding Co runs the higher net margin — -961.9% vs -2222.2%, a 1260.2% gap on every dollar of revenue. On growth, Virgin Galactic Holdings, Inc posted the faster year-over-year revenue change (125.5% vs -67.8%).
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.
SCLX vs SPCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $4.2M |
| Net Profit | $-46.1M | $-93.8M |
| Gross Margin | 45.5% | -546.6% |
| Operating Margin | -2317.8% | -2412.1% |
| Net Margin | -961.9% | -2222.2% |
| Revenue YoY | -67.8% | 125.5% |
| Net Profit YoY | -613.7% | 30.2% |
| EPS (diluted) | $-4.63 | $-4.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.8M | — | ||
| Q3 25 | $10.6M | — | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $16.4M | $4.2M | ||
| Q1 24 | $10.9M | $2.0M |
| Q4 25 | $-46.1M | — | ||
| Q3 25 | $-257.8M | — | ||
| Q2 25 | $-44.0M | — | ||
| Q1 25 | $-26.1M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $-4.4M | — | ||
| Q2 24 | $-37.6M | $-93.8M | ||
| Q1 24 | $-24.4M | $-102.0M |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 68.5% | — | ||
| Q2 25 | 66.9% | — | ||
| Q1 25 | 72.3% | — | ||
| Q4 24 | 68.5% | — | ||
| Q3 24 | 73.9% | — | ||
| Q2 24 | 73.2% | -546.6% | ||
| Q1 24 | 64.7% | -1038.1% |
| Q4 25 | -2317.8% | — | ||
| Q3 25 | -1766.2% | — | ||
| Q2 25 | -207.2% | — | ||
| Q1 25 | -557.5% | — | ||
| Q4 24 | -190.5% | — | ||
| Q3 24 | -138.0% | — | ||
| Q2 24 | -95.4% | -2412.1% | ||
| Q1 24 | -179.0% | -5599.9% |
| Q4 25 | -961.9% | — | ||
| Q3 25 | -2441.5% | — | ||
| Q2 25 | -445.1% | — | ||
| Q1 25 | -521.2% | — | ||
| Q4 24 | -43.4% | — | ||
| Q3 24 | -30.4% | — | ||
| Q2 24 | -229.6% | -2222.2% | ||
| Q1 24 | -224.0% | -5139.1% |
| Q4 25 | $-4.63 | — | ||
| Q3 25 | $-22.17 | — | ||
| Q2 25 | $-7.42 | — | ||
| Q1 25 | $-2.26 | — | ||
| Q4 24 | $8.53 | — | ||
| Q3 24 | $-0.58 | — | ||
| Q2 24 | $-7.67 | $-4.36 | ||
| Q1 24 | $-8.33 | $-5.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $775.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-207.8M | $394.8M |
| Total Assets | $365.0M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | — | ||
| Q3 25 | $878.0K | — | ||
| Q2 25 | $4.1M | — | ||
| Q1 25 | $5.8M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $77.0K | — | ||
| Q2 24 | $6.9M | $775.7M | ||
| Q1 24 | $1.8M | $765.2M |
| Q4 25 | $-207.8M | — | ||
| Q3 25 | $-176.9M | — | ||
| Q2 25 | $-249.0M | — | ||
| Q1 25 | $-211.5M | — | ||
| Q4 24 | $-192.6M | — | ||
| Q3 24 | $-211.3M | — | ||
| Q2 24 | $-214.7M | $394.8M | ||
| Q1 24 | $-189.8M | $417.6M |
| Q4 25 | $365.0M | — | ||
| Q3 25 | $275.9M | — | ||
| Q2 25 | $83.8M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $93.0M | — | ||
| Q3 24 | $100.4M | — | ||
| Q2 24 | $104.5M | $1.1B | ||
| Q1 24 | $91.2M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-17.5M | $-79.1M |
| Free Cash FlowOCF − Capex | — | $-113.5M |
| FCF MarginFCF / Revenue | — | -2690.7% |
| Capex IntensityCapex / Revenue | — | 815.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-458.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-17.5M | — | ||
| Q3 25 | $8.2M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $5.1M | — | ||
| Q2 24 | $2.3M | $-79.1M | ||
| Q1 24 | $9.4M | $-113.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-113.5M | ||
| Q1 24 | — | $-126.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2690.7% | ||
| Q1 24 | — | -6362.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | 815.5% | ||
| Q1 24 | — | 658.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
